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Effective Refractory Periods in the Right Atrium in Patients with
Atrioventricular Nodal Reentrant Tachycardia
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GAKU SEKITA,2 YASUNOBU KAWANO,2 KAORU NAKAZATO,2 MASATAKA SUMIYOSHI,3 HIROYUKI
DAIDA2
From 1Department of Cardiology, Juntendo University Urayasu Hospital; 2Department of Cardiology, Juntendo
University School of Medicine; 3Department of Cardiology, Juntendo University Nerima Hospital, Japan
TOKANO ET AL.: Effective Refractory Periods in the Right Atrium in Patients with Atrioventricular Nodal
Reentrant Tachycardia. Introduction: Atrial flutter and fibrillation (AFL/AF) are frequently induced in patients
with atrioventricular nodal reentrant tachycardia (AVNRT), however, its mechanism is uncertain. The purpose of this
study was to determine characteristics of effective refractory periods in the right atrium (RA) in patients with AVNRT.
Methods and Results: In 26 patients with typical AVNRT (21 female, mean 46-year-old), AFL/AF was induced in
9 (35%) patients during an electrophysiologic study before slow pathway (SP) ablation. The atrial effective refractory
periods (A-ERP) were measured at the high, mid and low lateral wall in the RA, the high and mid RA septum, and the
SP region. Dispersion in the A-ERP (the longest − shortest; ERPD) was also calculated. The data was compared with
28 patients with intra- or infra-nodal atrioventricular block (AVB) and 32 patients with sinus node dysfunction
(SND). The mean A-ERP was from 196 to 220 msec excepting at the SP region. The A-ERP at the SP region was
significantly longer comparing with those at the other sites (mean 242 msec, p<0.05). Similar tendency was found in
patients with SND, not in patients with AVB. The ERPD was significantly greater than that in patients with AVB
(mean 72 versus 45 msec, respectively, p<0.05) while it was similar to that in patients with SND (mean 78 msec).
Conclusion: In patients with AVNRT, the A-ERP in the SP region was relatively prolonged and the ERPD was wide
as in patients with SND. These atrial electrophysiologic abnormalities might be potentially arrythmogenesis for
atrial tachyarrythmias other than AVNRT. (J HK Coll Cardiol 2012;20:31-37)
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Introduction
Atrioventricular nodal reentrant tachycardia
(AVNRT) is a common supraventricular tachyarrhythmia
in the clinical setting. An electrophysiologic study (EPS)
is performed for its diagnosis, usually before slow
pathway (SP) ablation. Previous studies have reported
that atrial flutter and/or fibrillation (AFL/AF) are
frequently complicated and induced during the EPS
in patients with AVNRT.1-8 However, the details of
AFL/AF coexistence with AVNRT is still not clear.
The purpose of this study is to determine
electrophysiologic characteristics of the right atrium
(RA), especially effective refractory periods and its
dispersion, in patients with AVNRT.

Methods
The study subjects were 26 patients with a typical
(slow-fast form) AVNRT and structurally normal heart
in whom an EPS and subsequent SP ablation were
performed. Twenty-one patients were female and
remaining 5 patients were male. The age was 46.1±14.9
(range 21-76) year-old. All patients did not have a
natural history of AFL/AF. The patients with underlying
cardiovascular disease such as coronary artery disease,
cardiomyopathy, valvular heart disease, hypertension
and the other kind of arrhythmias were not included in
this study subject. Therefore, patients who showed
abnormal findings on the chest X-rays, baseline 12 leads
electrocardiogram and echocardiogram were excluded
in this study.
The baseline EPS was performed using standard
techniques at unsedated fashion. Briefly, quadpolar
electrodes catheters were placed at the high RA, His
bundle region and the right ventricular apex. A decapolar
electrodes catheter was placed in the coronary sinus. To
minimize the effect of pacing on the atrial refractoriness,
atrial effective refractory periods (A-ERP) in the six
different sites in the RA were measured using the atrial
extra-stimuli at a basic cycle length of 600 msec with
10 msec gradual decrement moving a quadpolar
electrodes catheter at high, mid and low lateral wall in
the RA, high and mid RA septum, and low RA septum
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(SP region). If an AVNRT was induced, it was
immediately terminated with an atrial or ventricular
burst pacing as soon as possible. Then, routine study
included an atrial burst pacing up to a rate of 200 pacing
per minute, sinus node overdrive suppression test, a
ventricular burst pacing and ventricular extra-stimuli
were performed. Inducibility of AFL/AF in the EPS that
lasted over 10 seconds was also noted. We defined the
dispersion in A-ERP (ERPD) as the difference in the
longest and shortest A-ERP among the six sites in the
RA. If AVNRT was not induced, subsequent provocative
EPS was performed. However, the all A-ERP data was
obtained before the routine baseline EPS.
The ERPD was compared with those in 28
patients with intra- and infra-Hisian atrioventricular
block (AVB) without episodes of any atrial
tachyarrhythmias (age: 76.8±10.5 year-old, 11 male)
and 32 patients with sinus node dysfunction (SND) (age:
77.0±10.4 year-old, 15 male). In the group of SND, AFL/
AF were clinically documented before the EPS in 15
patients (47%). In contrast, patients who had a history
of AFL/AF were not included in the group of AVB. In
these patients group, coronary sinus catheter was not
placed, however, A-ERPs in the RA and ERPD were
obtained using same technique in patients with AVNRT.
Inclusions for these patients group were indicated in
Table 1.
All patients were provided written consent to this
study approved by the institutional research ethics
committee.

Results
All patients showed a dual atrioventricular nodal
physiology and induced a typical AVNRT by using the
atrial burst pacing and/or extra-stimuli during the EPS.
No patients showed findings that indicated SND and
abnormal atrioventricular and intraventricular
conduction.
AFL/AF was induced in 9 (35%) patients. AFL
was induced in 3 patients, and AF was induced in
3 patients. In the remaining 3 patients, both AFL and
AF were induced. The intracardiac electrocardiogram
indicated that the earliest activation site at the
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onset of the induced AFL/AF was in the RA in all these
9 patients. The induced AFL/AF was not sustained
excepting for AFL in 1 patient, however, this sustained
AFL also spontaneously terminated within 1 minute.
A typical case was shown in Figure 1.
The A-ERP at the six sites in the RA in patients
with AVNRT were showed in Figure 2, and those in
all patient groups were shown in Figure 3. As shown

in Figures 2 and 3, the A-ERP at the SP region was
significantly longer comparing with those at the other
sites in the RA in patents with AVNRT (p<0.05). The
ERPD was calculated as 72.3±28.0 msec in the study
subjects (Figure 2). It was similar to that in patients
with SND, and there was a significant difference in
the ERPD between patients with AVNRT and AVB
(p<0.05, Figure 4).

Table 1. Inclusions for compared group of patients with sinus node dysfunction (SND) and atrioventricular
block (AVB)
Heart rate >60/min for patients with SND and >40/min AVB even if escape rhythm
Hemodymamically stable, no complication of heart failure
No continuous pacing is required
No marked atrial enlargement such as atrial diameter >45 mm
For patients with chronic AVB;
No history of atrial tachyarrhythmia
The study performed within 4 weeks from the occurrence of chronic AVB
The site of AVB was within or below the His-bundle

Panel A

Panel B

Figure 1. Intracardiac electrocardiogram in a typical case in which atrial flutter was induced.
This case was a 49 year-old male with a narrow QRS tachycardia in whom atrial flutter and fibrillation had not been documented.
During an electrophysiologic study, transient atrial flutter that lasted approximately 10 seconds was induced by an atrial extra
stimuli (basic cycle length: 600 msec, S1-S2: 210 msec, panel A). The clinical tachycardia was induced by a double atrial extra
stimuli (basic cycle length: 500 msec, S1-S2: 250 msec, S2-S3: 210 msec) under isoproterenol infusion that compatible with a
typical atrioventricular reentrant tachycardia (panel B).
II, V1: surface electrocardiogram, HRA: high right atrium, HBE: His bundle electrogram, CS: coronary sinus, RVA: right ventricular
apex, S: electrical stimulation, A: atrial activity, H: His-bundle activity, V: ventricular activity.
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Figure 2. The effective refractory periods at the six sites in the right atrium in 26 patients with atrioventricular nodal reentrant
tachycardia.
The atrial effective refractory periods at the slow pathway region was significantly longer comparing with those at the other sites
in the right atrium (RA) (p<0.05). The dispersion in effective refractory periods (ERPD) was calculated as 72.3±28.0 msec.
HLRA: high lateral RA, MLRA: mid lateral RA, LLRA: low lateral RA, HSRA: high septal RA, MSRA: mid septal RA,
CSOS: coronary sinus ostium, SVC: superior vena cava, IVC: inferior vena cava, TV: tricuspid valve.

Figure 3. The effective refractory periods at the six sites in the right atrium (RA) in patients with atrioventricular nodal
reentrant tachycardia, atrioventricular block and sinus node dysfunction.
The atrial effective refractory periods (A-ERP) with atrioventricular nodal reentrant tachycardia (AVNRT), intra- and infra-Hisian
atrioventricular block (AVB) without episodes of any atrial tachyarrhythmias, and sinus node dysfunction (SND) were shown.
HLRA: high lateral RA, MLRA: mid lateral RA, LLRA: low lateral RA, HSRA: high septal RA, MSRA: mid septal RA, SP: slow
pathway.
34
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Figure 4. Comparison of dispersion in the effective refractory periods in the right atrium among the patients group.
Dispersion in the effective refractory periods (ERPD) in patients with atrioventricular nodal reentrant tachycardia (AVNRT) was
similar to that in patients with sinus node dysfunction (SND), and there was a significant difference in the ERPD between patients
with AVNRT and SND comparing with patients who had intra- and infra-Hisian atrioventricular block (AVB) without episodes of
any atrial tachyarrhythmias (p<0.05).

Discussion
The major findings of this study was that transient
AFL/AF was induced in approximately one third of
patients with AVNRT, and the ERPD in the RA was
about the same as in patients with SND.
As in previous studies, paroxysmal AFL/AF is
frequently observed in patients with AVNRT.1,6 Before
catheter ablation era, Hurwitz et al described that AF
was documented in 26% patients with AVNRT during
10 years follow-up.1 Kimman et al reported that AFL/
AF was observed in 17% patients after successful slow
and/or fast pathway ablation for AVNRT.6 In addition,
AFL/AF was also frequently induced in patients with
AVNRT during EPS in the other previous studies.2,5,8
Razani et al reported that AF was induced in 8% of
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patients with AVNRT who did not have a history of AF,
and the induction rate was increased to 67% if more
aggressive protocol for AF induction was employed.8 It
was not unusual that AVNRT initiates paroxysmal AF
in previous studies as well.4,7 Regarding to the study
reported by Sauer et al, AVNRT was induced in 4.3% of
patients with paroxysmal AF, and AF was cured by SP
ablation for AVNRT without pulmonary vein isolation
in most of those patients.7 This study did not include
the patients who had documented clinical episodes of
AFL/AF, however, the induction rate of transient AFL/
AF during an EPS in this study was similar to those in
previous studies.2,8
The inducing mechanism of AFL/AF in patients
with AVNRT is still not clear. Hurwitz et al suggested
that "so-called" remodeling of atrial tissue due to
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sustained AVNRT may have caused AF.1 AF that was
degenerated from AVNRT might be related to this
mechanism. In this study, we terminated induced
AVNRT as soon as possible by atrial or ventricular burst
pacing. In some patients of the study subject, AFL/AF
was already induced before the first induction of
AVNRT (Figure 2), therefore, remodeling of atrial tissue
due to sustained AVNRT may be ruled out. Kimman et
al emphasized in their report that ablation lesion may
have related to the occurrence of AFL/AF as a new
arrhythmia after slow and/or fast pathway ablation.6
However, most of previous studies and our study
demonstrated that frequent AFL/AF induction was
observed before ablation, therefore, this mechanism is
not considerable. Decrease in the vulnerability to pacinginduced AF after SP ablation may have direct or indirect
effect on AF substrate.8 The study suggested the effect
of SP ablation on atrial vagal tone.8 The SP contributes
to the reentrant circuit for AVNRT, however, it exists in
atrial tissue surrounding the compact atrioventricular
node, but not within the compact atrioventricular node
itself. Regarding that the SP is an abnormal atrial tissue,
it may play a role as slow conduction zone for the other
kind of atrial reentrant tachycardia such as AFL/AF.
Kimman et al also pointed out that 4 patients had preexisted type 1 AFL and the AFL was cured with ablation
technique for AVNRT,6 while the other study showed
no effect of SP ablation on inducibility of AFL.2 If so,
the ERPD in the RA might be wide in patients with
AVNRT.
On the other hand, SND is considered to be an
atrial disease which is frequently complicated with AFL/
AF. Expanded ERPD in the RA myocardium may be
related to the occurrence of AFL/AF as shown in
previous studies.9-13 Our previous report also found that
the ERPD was significantly wider in SND if it was
compared with that in patients without AFL/AF such as
the patients who had only intra-Hisain and infra-Hisian
conduction disturbance.13 This study demonstrated that
the ERPD in patients AVNRT was wider comparing to
almost the same control group of patients with SND,
and the relatively longer A-ERP at the SP region may
contribute to the wider ERPD.
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Study Limitation
In patients with AFL/AF, the left atrial tissue and
pulmonary veins are also arrhythmia origin. We did not
discuss about the A-ERP in the left atrium in this study.
However, all induced AFL/AF showed that the earliest
activation site at the onset was in the RA, not in the
coronary sinus. So, induced AFL/AF that was
considered to be the left atrium origin was not included
in this analysis. Therefore, the results and discussion in
this study were reasonable for AFL/AF that was
originated from the RA and complicated in the patients
with AVNRT. In addition, detail RA mapping to identify
the reentrant circuit of induced AFL/AF employing Halo
catheter or electroanatomical mapping system was not
performed in this study, therefore, it was not proved
that prolonged A-ERP at the SP region and relatively
wide ERPD in the RA was directly related to the
occurrence of AFL/AF.
The results of this study were potentially
influenced by several factors. This study was not
controlled study. The patients with AVB were not
"true" control group. Regarding to the A-ERP in the
patients with AVB, those were relatively longer
comparing with the patients with AVNRT. It indicated
that the patients with AVB could not be treated as "a
normal RA group". Long lasting bradycardia,
artificial pacing and heart failure may have caused
atrial electorophisiologic change and affected on the
results of this study. The data should have been
compared with that in the "true" control group with
completely normal heart such as younger patients
who underwent an EPS for evaluation of syncope
unknown origin, however, obtaining ERPD data from
comparable number of such patients was very difficult
in the clinical setting. Therefore, we carefully
selected these patients as a patients group that had
not AFL/AF minimizing the potential impacts on the
study results other than unavoidable age difference
due to general patient population as shown in Table
1, and the comparison in this study was considered
to be also meaningful. Pacing maneuver and induction
of AVNRT may have also influenced on the A-ERP.
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Therefore, the measurement of A-ERP was already
completed before routine EPS was done without any
pharmacological interventions. If AVNRT was induced
during the measurement of A-ERP, it was immediately
terminated as described in the methodology.
The number of patients in the study was relatively
small, so further patients collection was required for
more discussion such as relationship to induced and
especially clinical AFL/AF.

Conclusion
The A-ERP in the RA surrounding the SP was
relatively prolonged and the ERPD in patients with
AVNRT was as wide as in patients with SND. These
atrial electophysiologic abnormalities might be
potentially arrythmogenic for atrial tachyarrythmias in
patients with AVNRT despite unuseful AV nodal
modification.
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